The Haystack Project
  • Home
  • About Us Participants Partners Board and Advisors
  • Priorities
  • PROTECT Rare
  • Modernizing-FDA HEART Act
  • Speaker Series Payer Engagement Health Equity Patient Oriented Value Rare Cancer
  • Inflation Reduction Act Medicare Section 340b Medicaid FDA ICER
  • Patient Stories
  • Join
  • Take Action
The Haystack Project
  • Home/
  • About/
    • About Us
    • Participants
    • Partners
    • Board and Advisors
  • Priorities/
  • PROTECT Rare/
  • FDA/
    • Modernizing-FDA
    • HEART Act
  • Programs/
    • Speaker Series
    • Payer Engagement
    • Health Equity
    • Patient Oriented Value
    • Rare Cancer
  • Policy/Comments/
    • Inflation Reduction Act
    • Medicare
    • Section 340b
    • Medicaid
    • FDA
    • ICER
  • Patient Stories/
  • Join/
  • Take Action/
Blue-Banner.png
The Haystack Project

Resources

The Haystack Project
  • Home/
  • About/
    • About Us
    • Participants
    • Partners
    • Board and Advisors
  • Priorities/
  • PROTECT Rare/
  • FDA/
    • Modernizing-FDA
    • HEART Act
  • Programs/
    • Speaker Series
    • Payer Engagement
    • Health Equity
    • Patient Oriented Value
    • Rare Cancer
  • Policy/Comments/
    • Inflation Reduction Act
    • Medicare
    • Section 340b
    • Medicaid
    • FDA
    • ICER
  • Patient Stories/
  • Join/
  • Take Action/
October 27, 2026

Woodcock: New paradigm needed to unlock therapies for rare diseases→

October 27, 2026/ Tiara Logan

Read here.

October 27, 2026/ Tiara Logan/ /Source
News
FDA

Tiara Logan

October 23, 2026

This ‘living drug’ could change the course of autoimmune disease→

October 23, 2026/ Tiara Logan

Read here.

October 23, 2026/ Tiara Logan/ /Source
Patient Stories

Tiara Logan

October 23, 2026

The inherited disease my family called ‘it’ had a name, which changed everything→

October 23, 2026/ Tiara Logan

Read here.

October 23, 2026/ Tiara Logan/ /Source
Patient Stories

Tiara Logan

October 14, 2026

Press Release the FDA Initiative 10.13.26→

October 14, 2026/ Tiara Logan

Read here.

October 14, 2026/ Tiara Logan/ /Source
News
FDA, press release

Tiara Logan

October 02, 2026

Haystack Senate RFI Comments 10.2.26→

October 02, 2026/ Tiara Logan

Read here.

October 02, 2026/ Tiara Logan/ /Source
Comment Letters, Letters
Medicaid, Medicare

Tiara Logan

October 02, 2026

FDA Substantial Evidence Draft Guidance Met With Opposition From Consumer Group→

October 02, 2026/ Tiara Logan

Read Here.

October 02, 2026/ Tiara Logan/ /Source
News
FDA

Tiara Logan

September 22, 2026

Haystack Substantial Evidence 9.22.26→

September 22, 2026/ Tiara Logan

Read here.

September 22, 2026/ Tiara Logan/ /Source
Comment Letters, Letters
FDA

Tiara Logan

September 16, 2026

Gene-Silencing Therapies Face Different Bar Under US FDA Plausible Mechanism Framework→

September 16, 2026/ Tiara Logan

Read here.

September 16, 2026/ Tiara Logan/ /Source
News
FDA

Tiara Logan

August 27, 2026

Haystack Project- FDA, CMS Statute Changes Needed Before Drug Repurposing→

August 27, 2026/ Tiara Logan

Read here.

August 27, 2026/ Tiara Logan/ /Source
News
FDA

Tiara Logan

August 18, 2026

Haystack IPAY 2029 Comments 8.17.26→

August 18, 2026/ Tiara Logan

Read here.

August 18, 2026/ Tiara Logan/ /Source
Comment Letters, Letters
cms, IRA

Tiara Logan

July 22, 2026

'Too Rare to Care’? A New Center for Rare Diseases Hopes to Change That→

July 22, 2026/ Tiara Logan

Read here.

July 22, 2026/ Tiara Logan/ /Source
Patient Stories

Tiara Logan

July 06, 2026

Auchincloss Leg Specs Feedback 7.6.26→

July 06, 2026/ Tiara Logan

Read here.

July 06, 2026/ Tiara Logan/ /Source
Comment Letters, Letters
FDA

Tiara Logan

May 19, 2026

ICD Ultra-Rare Framework Comment →

May 19, 2026/ Tiara Logan

Read here.

May 19, 2026/ Tiara Logan/ /Source
Letters, Comment Letters
Medicare

Tiara Logan

May 19, 2026

Plausible Mechanism Pathway Comments→

May 19, 2026/ Tiara Logan

Read here.

May 19, 2026/ Tiara Logan/ /Source
Comment Letters, Letters
FDA

Tiara Logan

April 09, 2026

PRESS RELEASE: Haystack Project Files Petition for Rulemaking to Establish Context-Based Evidence Framework for Rare Diseases→

April 09, 2026/ Tiara Logan

Read here.

April 09, 2026/ Tiara Logan/ /Source
News
FDA

Tiara Logan

April 09, 2026

Haystack Project Petitions FDA To Adopt Context-Driven Evidence Approach For Rare Therapies→

April 09, 2026/ Tiara Logan

Read here.

April 09, 2026/ Tiara Logan/ /Source
News
FDA

Tiara Logan

April 02, 2026

Haystack Project’s Petition for Rulemaking→

April 02, 2026/ Tiara Logan

Read here.

April 02, 2026/ Tiara Logan/ /Source
Comment Letters, Letters
FDA

Tiara Logan

January 26, 2026

Haystack MA Part D comment 1.26.26

January 26, 2026/ Tiara Logan

Read here.

January 26, 2026/ Tiara Logan/ /Source
Comment Letters, Letters
Medicare

Tiara Logan

January 05, 2026

RDEP Open Letter to FDA→

January 05, 2026/ Tiara Logan

Read here.

January 05, 2026/ Tiara Logan/ /Source
Comment Letters, Letters
FDA

Tiara Logan

September 05, 2025

Experts: New FDA Rare Disease Program Offers Nothing Novel→

September 05, 2025/ Tiara Logan

Read here.

September 05, 2025/ Tiara Logan/ /Source
News
FDA

Tiara Logan

  • Next

About Us

The Issues

Resources

News & Updates

© 2020 Haystack Project. All Rights Reserved. 

 

Contact Us

Please consider making a tax-deductible donation to support the Haystack Project today.

The Haystack Project is a 501(c)3 nonprofit that brings together patients organizations representing patients suffering from or caring for patients with extremely rare diseases. Our mission is to educate policymakers and other stakeholders about the need for policies that recognize the unique circumstances of extremely rare conditions and treatments and expand incentives critical to ensuring they can reach patients.